PC_061 Long-term Efficacy and Safety of Hexaminolevulinate Photodynamic Therapy (HAL-PDT) in CIN2 Patients: Results from a Phase III Randomized Controlled Trial

L. Zhu (1), P. Hillemanns (2), F. Chen (1), H. Ruan (3), Z. Novak (4), L. Woelber (5), L. Sui (6), B. Li (7), J. Lang (1)
(1) Peking Union Medical College Hospital, Beijing, Chine, (2) Medizinische Hochschule Hannover, Hannover, Allemagne, (3) Nanjing Maternity And Child Health Hospital, Nanjing, Chine, (4) Aranyklinika Gynaecology, Budapest, Hongrie, (5) University Medical Centre Hamburg-Eppendorf, Hamburg, Allemagne, (6) Obstetrics & Gynecology Hospital Of Fudan University, Shanghai, Chine, (7) Asieris Pharmaceuticals, Shanghai, Chine